Li M - Search Results

1

A Novel Pre-treatment Model Predicting Risk of Developing Refractoriness to Transarterial Chemoembolization in Unresectable Hepatocellular Carcinoma.

Hu K, Lu S, Li M, Zhang F, Tang B, Yuan J, Shan Y, Xu P, Chen R, Ren Z, Yin X. Hu K, et al. Among authors: li m. J Cancer. 2020 May 18;11(15):4589-4596. doi: 10.7150/jca.44847. eCollection 2020. J Cancer. 2020. PMID: 32489476 Free PMC article.

2

Peripheral blood neutrophil count as a prognostic factor for patients with hepatocellular carcinoma treated with sorafenib.

Yuan J, Liang H, Li J, Li M, Tang B, Ma H, Xie X, Yin X, Zhang L, Ren Z. Yuan J, et al. Among authors: li j, li m. Mol Clin Oncol. 2017 Nov;7(5):837-842. doi: 10.3892/mco.2017.1416. Epub 2017 Sep 19. Mol Clin Oncol. 2017. PMID: 29181175 Free PMC article.

3

A new substage classification strategy for Barcelona Clinic Liver Cancer stage B patients with hepatocellular carcinoma.

Hu KS, Tang B, Yuan J, Lu SX, Li M, Chen RX, Zhang L, Ren ZG, Yin X. Hu KS, et al. Among authors: li m. J Gastroenterol Hepatol. 2019 Nov;34(11):1984-1991. doi: 10.1111/jgh.14673. Epub 2019 May 14. J Gastroenterol Hepatol. 2019. PMID: 30932246

4

A New Scoring Method for Personalized Prognostic Prediction in Patients with Combined Hepatocellular and Cholangiocarcinoma After Surgery.

Zhang F, Hu K, Tang B, Tian M, Lu S, Yuan J, Li M, Chen R, Ren Z, Shi Y, Yin X. Zhang F, et al. Among authors: li m. J Gastrointest Surg. 2021 Apr;25(4):971-982. doi: 10.1007/s11605-020-04618-2. Epub 2020 Apr 29. J Gastrointest Surg. 2021. PMID: 32350718

5

Matrix stiffness-mediated effects on macrophages polarization and their LOXL2 expression.

Xing X, Wang Y, Zhang X, Gao X, Li M, Wu S, Zhao Y, Chen J, Gao D, Chen R, Ren Z, Zhang K, Cui J. Xing X, et al. Among authors: li m. FEBS J. 2021 Jun;288(11):3465-3477. doi: 10.1111/febs.15566. Epub 2020 Oct 6. FEBS J. 2021. PMID: 32964626 Free article.

6

The pathological significance of LOXL2 in pre-metastatic niche formation of HCC and its related molecular mechanism.

Wu S, Xing X, Wang Y, Zhang X, Li M, Wang M, Wang Z, Chen J, Gao D, Zhao Y, Chen R, Ren Z, Zhang K, Cui J. Wu S, et al. Among authors: li m. Eur J Cancer. 2021 Apr;147:63-73. doi: 10.1016/j.ejca.2021.01.011. Epub 2021 Feb 19. Eur J Cancer. 2021. PMID: 33618200

7

Prognostic significance of preoperative systemic immune-inflammation index in combined hepatocellular-cholangiocarcinoma.

Zhang F, Hu KS, Lu SX, Li M, Chen RX, Ren ZG, Shi YH, Yin X. Zhang F, et al. Among authors: li m. Cancer Biomark. 2021;31(3):211-225. doi: 10.3233/CBM-200643. Cancer Biomark. 2021. PMID: 33896819

8

The Prognostic Value of the Albumin to Gamma-Glutamyltransferase Ratio in Patients with Hepatocellular Carcinoma Undergoing Radiofrequency Ablation.

Liu W, Zhang F, Quan B, Li M, Lu S, Li J, Chen R, Yin X. Liu W, et al. Among authors: li j, li m. Dis Markers. 2021 Nov 19;2021:3514827. doi: 10.1155/2021/3514827. eCollection 2021. Dis Markers. 2021. PMID: 34840628 Free PMC article.

9

First-Line Systemic Treatment Strategies for Unresectable Hepatocellular Carcinoma: A Systematic Review and Network Meta-Analysis of Randomized Clinical Trials.

Liu W, Quan B, Lu S, Tang B, Li M, Chen R, Ren Z, Yin X. Liu W, et al. Among authors: li m. Front Oncol. 2021 Dec 24;11:771045. doi: 10.3389/fonc.2021.771045. eCollection 2021. Front Oncol. 2021. PMID: 35004289 Free PMC article.

10

Zhang F, Cai J, Hu K, Liu W, Lu S, Tang B, Li M, Wu W, Ren Z, Yin X. Zhang F, et al. Among authors: li m. Comb Chem High Throughput Screen. 2022;25(13):2203-2216. doi: 10.2174/1386207325666220304115006. Comb Chem High Throughput Screen. 2022. PMID: 35249477

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

74,258 results

Search Page

Filters